View:
Securities and Exchange Commission, Washington, D.C. 20549
Schedule 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
____________________________________________________________________
(Name of Issuer) Tekmira Pharmaceuticals Corp
____________________________________________________________________
(Title of Class of Securities) COM
____________________________________________________________________
(CUSIP Number) 87911B209
____________________________________________________________________
(Date of Event Which Requires Filing of this Statement) Year-end Reporting
Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:
[x] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.
The information required in the remainder of this cover page shall
not be deemed to be ``filed'' for the purpose of Section 18 of the
Securities Exchange Act of 1934 (``Act'') or otherwise subject to the
liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).
CUSIP No. 87911B209
(1) Names of reporting persons...BMO Financial Corp
I.R.S. Identification Nos. of above persons (entities only)
51-0275712
--------------------------------------------------------------------
(2) Check the appropriate box if a member of a group
(a)
(b) x
(3) SEC use only...................................................
--------------------------------------------------------------------
(4) Citizenship or place of organization............................
A Delaware Corporation
--------------------------------------------------------------------
Number of shares beneficially owned by each reporting person with:
(5) Sole voting power...772,181...............................
(6) Shared voting power....0...........................
(7) Sole dispositive power......772,181......................
(8) Shared dispositive power....0.......................
--------------------------------------------------------------------
(9) Aggregate amount beneficially owned by each reporting person
772,181
--------------------------------------------------------------------
* Beneficial ownership of 0 shares is specifically disclaimed.
See item 4.
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)..................................................
--------------------------------------------------------------------
(11) Percent of class represented by amount in Row (9)...5.512%.......
---------------------------------------------------------------------
(12) Type of reporting person (see instructions)....HC.............
--------------------------------------------------------------------
Page--of--Pages-----------------------------------------------------
Item 1(a) Name of issuer:
Tekmira Pharmaceuticals Corp
Item 1(b) Address of issuer's principal executive offices:
100-8900 Glenlyon Parkway
Burnaby, Canada V5J 5J8
2(a) Name of person filing: BMO Financial Corp
_____________________________________________________________________
2(b) Address or principal business office or, if none, residence:
111 W. Monroe Street
P. O. Box 755
Chicago, IL 60690
_____________________________________________________________________
2(c) Citizenship: A Delaware Corporation
_____________________________________________________________________
2(d) Title of class of securities: COM
_____________________________________________________________________
2(e) CUSIP No.: 87911B209
_____________________________________________________________________
Item 3. If this statement is filed pursuant to Secs. 240.13d-1(b)
or 240.13d-2(b) or (c), check whether the person filing is a:
(a) [ ] Broker or dealer registered under section 15 of the Act
(15 U.S.C. 78o).
(b) [X] Bank as defined in section 3(a)(6) of the Act (15 U.S.C.
78c).
(c) [ ] Insurance company as defined in section 3(a)(19) of the
Act (15 U.S.C. 78c).
(d) [ ] Investment company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C 80a-8).
(e) [ ] An investment adviser in accordance with Sec. 240.13d-
1(b)(1)(ii)(E);
(f) [ ] An employee benefit plan or endowment fund in accordance
with Sec. 240.13d-1(b)(1)(ii)(F);
(g) [X] A parent holding company or control person in accordance
with Sec. 240.13d-1(b)(1)(ii)(G);
(h) [ ] A savings associations as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) [ ] A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment Company
Act of 1940 (15 U.S.C. 80a-3);
(j) [ ] Group, in accordance with Sec. 240.13d-1(b)(1)(ii)(J).
Item 4. Ownership
1.
(a) Amount beneficially owned: 772,181
(b) Percent of class: 5.512%
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote 772,181
(ii) Shared power to vote or to direct the vote 0
(iii) Sole power to dispose or to direct the disposition of
772,181
(iv) Shared power to dispose or to direct the disposition of
0
Item 5. Ownership of 5 Percent or Less of a Class. If this statement
is being filed to report the fact that as of the date hereof the
reporting person has ceased to be the beneficial owner of more than 5
percent of the class of securities, check the following [ ].
See Exhibit 2
Item 6. Ownership of More than 5 Percent on Behalf of Another
Person.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding Company
or Control Person.
BMO FINANCIAL CORP
111 WEST MONROE STREET
P O BOX 755
FLOOR 2W
CHICAGO, ILL 60690
BMO HARRIS BANK NA
111 West Monroe Street
Floor 6E
Chicago , IL 60690
BMO ASSET MANAGEMENT CORP
190 South La Salle Street
P. O. Box 755
Chicago , IL 60603
STOKER OSTLER
4900 NORTH SCOTTSDALE ROAD
SUITE 2600
SCOTTSDALE, AZ 85251
BMO NESBITT BURNS INC
IBG Finance Dept
FCP - 7th Floor
Toronto , ON M5X 1H3 CANADA
BMO HARRIS INVESTMENT MANAGEMENT INC
1 First Canadian Place
P.O. Box 150
9th Floor
Toronto , ON M5X 1H3 CANADA
BMO ASSET MANAGEMENT, INC
Royal Trust Tower
77 King Street West
Suite 4200
Toronto , ON M5K 1J5 CANADA
SULLIVAN. BRUYETTE. SPEROS. BLANEY
8444 WESTPARK DRIVE
Suite 610
McLean , VA 22102
BMO HARRIS FINANCIAL ADVISORS, INC.
311 W. Monroe
14th Floor
Chicago , IL 60603
BMO FINANCIAL PRODUCTS CORP
3 Times Square
28th Floor
New York , NY 10036
BMO INVESTOR LINE INC
Attn: BMO INVESTOR LINE
Transit #3973
FIRST CANADIAN PLACE
100 KING STREET
FLOOR B1
Toronto , ON M5X 1H3 CANADA
Harris MyCFO
Suite 100
Menlo Park Site
Menlo Park, Ca 94025
BANK OF MONTREAL IRELAND PLC
2 Harbourmaster Place
6th Floor
Dublin, IE 1 1E
BMO Delaware Trust Company
20 Montchanin Road
Suite 240
Greenville, DE 19807
AMERICAN INTERNATIONAL GROUP
60 YONGE ST.
BMO LIFE BUILDING
TORONTO , ON M5E 1H5 CANADA
BMO CAPITAL MARKETS CORP (NY)
3 Times Square
28th Floor
New York , NY 10036
LLOYD GEORGE MANAGEMENT
SUITE 3808
ONE EXCHANGE SQUARE CENTRAL
HONG KONG , HK CHINA
MARSHALL & ILSLEY TRUST COMPANY N A
111 E. KILBOURN AVE
MILWAUKEE , WI 53202
NORTH STAR TRUST COMPANY
500 WEST MADISON STREET
CHICAGO, ILL. 60661-4580
TAPLIN CANIDA & HABACHT LLC
1001 BRICKELL BAY DRIVE
SUITE 2100
MIAMI, FLA 33131-4940
And filing on behalf of its parent:
Bank of Montreal
1 First Canadian Place
Toronto, Ontario Canada
MX5 1A1
Item 8. Identification and Classification of Members of the Group
See Exhibit 2
Item 9. Notice of Dissolution of Group.
Not Applicable
Item 10. Certification
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired and are held
in the ordinary course of business and were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a participant
in any transaction having that purpose or effect.
After reasonable inquiry and to the best of my knowledge
and belief, I certify that the information set forth in this statement
is true, complete and correct.
Dated: December 10, 2013
BMO FINANCIAL CORP.
BY: (Terry Jenkins)
Terry Jenkins
SVP & Head of Private Bank US
Schedule 13G
Exhibit 1
Pursuant to Rule 13d-1(k)(1)(iii)
Bank of Montreal,
BMO Financial Corp,
BMO Harris Bank NA,
BMO Asset Management Corp.
Stoker Ostler,
BMO Nesbitt Burns Inc,
BMO Harris Investment Management Inc,
BMO Asset Management, Inc.,
Sullivan Bruyette, Speros, Blaney,
BMO Harris Financial Advisors, Inc.,
BMO Financial Products Corp,
BMO Investorline Inc,
Harris MyCFO,
Bank of Montreal Ireland PLC,
BMO Delaware Trust Company,
American International Group,
BMO Capital Markets Corp (NY),
Lloyd George Management,
Marshall & Ilsley Trust Company, NA,
North Star Trust Company,
Taplin Canida & Habacht LLC
agree to this filing of Schedule 13G by BMO Financial Corp.
This exhibit is submitted as proof of their agreement and authorization
for BMO Financial Corp. to file on their behalf.
Dated: December 10 2013
BMO Financial Corp
By: (Terry Jenkins)
Terry Jenkins
SVP & Head of Private Bank US
BMO Harris Bank NA
By: (Terry Jenkins)
Terry Jenkins
SVP & Head of Private Bank US
BMO Asset Management Corp.
By: (Barry McInerney)
Barry McInerney
President & CEO
Stoker Ostler
By: (Creg D Ostler)
Creg D Ostler
Managing Director
BMO Nesbitt Burns Inc
By: (Robert Allair)
Robert Allair
Vice President & Managing Director
BMO Harris Investment Management Inc
By: (Michael Omran)
Michael Omran
Manager, Compliance & Risk Mgmt
BMO Asset Management, Inc.
By: (Dirk McRobb)
Dirk McRobb
SVP, Chief Administrative Officer, Chief Compliance Officer
Sullivan Bruyette, Speros, Blaney
By: (Greg Sullivan)
Greg Sullivan
Managing Director
BMO Harris Financial Advisors, Inc.
By: (Michael Miroballi)
Michael Miroballi
President & COO, HIS
BMO Financial Products Corp
By: (Ivan Gerstein)
Ivan Gerstein
VP - IBG Finance
BMO Investorline Inc
By: (Dirk McRobb)
Dirk McRobb
SVP, Chief Administrative Officer
Harris MyCFO
By: (Jo Ann Pantelis)
Jo Ann Pantelis
Manager - Compliance
Bank of Montreal Ireland PLC
By: (Jo Ann Pantelis)
Jo Ann Pantelis
Manager, Compliance
BMO Delaware Trust Company
By: (Terry jenkins)
Terry Jenkins
SVP & Head of Private Bank US
American International Group
By: (Dirk McRobb)
Dirk McRobb
SVP, Chief Administrative Officer
BMO Capital Markets Corp (NY)
By: (Ivan Gerstein)
Ivan Gerstein
VP - IBG Finance
Lloyd George Management
By: (Ellie Wong)
Ellie Wong
Controls & Compliance Officer
Marshall & Ilsley Trust Company, NA
By: (M Gayle Robinson)
M Gayle Robinson
SVP
North Star Trust Company
By: (M Gayle Robinson)
M Gayle Robinson
SVP
Taplin Canida & Habacht LLC
By: (Tere Alvarez Canida)
Tere Alvarez Canida
President
Schedule 13G
Exhibit 2
This Schedule is being filed by BMO Financial Corporation, its
parent company, Bank of Montreal.